Racial disparities in the receipt of adjuvant chemotherapy in patients with resected stage I-III pancreatic adenocarcinoma.

被引：0
|
作者：
Sanford, Nina Niu
Xu, Xiaohan
Sher, David J.
机构：
[1] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[2] UT Southwestern, Dallas, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 04期
关键词：
D O I：
10.1200/JCO.2019.37.4_suppl.357
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
357
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Disparities in Receipt of Adjuvant Immunotherapy among Stage III Melanoma Patients
    Mulligan, Kathleen M.
    Kakish, Hanna
    Pawar, Omkar
    Ahmed, Fasih Ali
    Elshami, Mohamedraed
    Rothermel, Luke D.
    Bordeaux, Jeremy S.
    Sheng, Iris Y.
    Mangla, Ankit
    Hoehn, Richard S.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2024, 47 (11): : 509 - 516
  • [12] Racial Disparities in the Outcomes of Patients With Stage IV Pancreatic Adenocarcinoma Are Mediated by Chemotherapy Utilization Reply
    Van Buren, George, II
    PANCREAS, 2016, 45 (07) : E34 - E35
  • [13] Meta-analysis of adjuvant chemotherapy versus no adjuvant chemotherapy for resected stage I pancreatic cancer
    Evans, Daisy
    Ghassemi, Nader
    Hajibandeh, Shahab
    Hajibandeh, Shahin
    Romman, Saleh
    Laing, Richard W.
    Durkin, Damien
    Athwal, Tejinderjit S.
    SURGERY, 2024, 175 (06) : 1470 - 1479
  • [14] Meta-analysis of adjuvant Chemotherapy versus no adjuvant Chemotherapy in resected Stage I Pancreatic Cancer
    Manekeller, Steffen
    ZENTRALBLATT FUR CHIRURGIE, 2024, 149 (04): : 338 - 338
  • [15] Does Delay of Adjuvant Chemotherapy Impact Survival in Patients With Resected Stage II and III Colon Adenocarcinoma?
    Bayraktar, Ulas Darda
    Chen, Emerson
    Bayraktar, Soley
    Sands, Laurence R.
    Marchetti, Floriano
    Montero, Alberto Jose
    Rocha-Lima, Caio Max S.
    CANCER, 2011, 117 (11) : 2364 - 2370
  • [16] Association of Adjuvant Chemotherapy in Patients With Resected Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy
    Sugawara, Toshitaka
    Rodriguez Franco, Salvador
    Sherman, Samantha
    Kirsch, Michael J.
    Colborn, Kathryn
    Ishida, Jun
    Grandi, Samuele
    Al-Musawi, Mohammed H.
    Gleisner, Ana
    Schulick, Richard D.
    Del Chiaro, Marco
    JAMA ONCOLOGY, 2023, 9 (03) : 316 - 323
  • [17] Outcomes of neoadjuvant chemotherapy versus chemoradiation among patients with resected pancreatic head adenocarcinoma.
    Franko, Jan
    Hsu, Harold W.
    Thirunavukarasu, Pragatheeshwar
    Frankova, Daniela
    Goldman, Charles David
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [18] Role of Chronic Inflammatory Ratios in Predicting Recurrence of Resected Patients with Stage I-III Mucinous Colorectal Adenocarcinoma
    Liao, Yu-Cui
    Ying, Hou-Qun
    Huang, Ying
    Luo, Yan-Ran
    Xiong, Cui-Fen
    Nie, Ruo-Wei
    Li, Xiao-Juan
    Cheng, Xue-Xin
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 3455 - 3464
  • [19] Impact of timing of adjuvant chemotherapy initiation on survival in pancreatic adenocarcinoma.
    Palacio, Sofia
    Ripat, Caroline
    Stuart, Heather
    Yakoub, Danny
    Merchant, Nipun B.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [20] Toxicity and outcomes of adjuvant chemoradiotherapy in patients with resected gastric adenocarcinoma.
    Kassam, Z
    Ringash, J
    Brierley, J
    Swallow, C
    Moore, M
    Knox, JJ
    Siu, L
    Wong, R
    Cummings, B
    Oza, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 347S - 347S
12345